Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
Clinical trial NCT04269200 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04269200
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2024-07-08
- Enrollment
- 805
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.